
https://www.science.org/content/blog-post/three-more-retractions
# Three More Retractions (March 2015)

## 1. SUMMARY

This article discusses a scientific misconduct scandal involving three additional retractions stemming from the Bielawski lab at the University of Texas. The retractions follow earlier findings that the lab's "unclick" chemistry work did not hold up under scrutiny. The problematic papers all involved a co-author named Kelly Wiggins, who had become difficult to locate. The American Chemical Society published these retractions in the Journal of the American Chemical Society, with each noting scientific misconduct by one of the co-authors affiliated with the university at the time.

The author reflects on the challenges of detecting research fraud, noting that when someone is determined to fabricate data thoroughly, it can be difficult to catch them quickly. The piece acknowledges that the scientific community often operates on trust, and that trust can be abused—sometimes for extended periods—before fraudulent work is discovered.

## 2. HISTORY

Following the March 2015 retractions, the scientific community continued grappling with research integrity issues related to this case and broader misconduct patterns. The Bielawski lab retractions represented part of a larger pattern of chemistry research misconduct that has persisted over the years.

Subsequent developments included heightened scrutiny of co-authorship practices and institutional responsibility for preventing and detecting fraud. The case contributed to ongoing discussions about whether senior authors and institutions should bear greater responsibility for verifying the integrity of research conducted under their supervision. Many journals and funding agencies implemented more stringent data verification and reproducibility requirements in the years following.

However, research misconduct has continued to be a persistent problem in scientific publishing, with retraction rates remaining a concern across multiple disciplines. While individual cases like this one received attention, systemic solutions have proven challenging to implement effectively.

## 3. PREDICTIONS

The article did not contain explicit predictions about future developments, instead focusing on the immediate implications of the retractions and the challenges of preventing research fraud.

## 4. INTEREST

Rating: **4/10**

This article addresses an important but unfortunately routine aspect of scientific publishing—research misconduct and retractions. While scientific integrity is crucial to the field, individual retraction cases, while concerning, represent a narrow slice of broader biotech industry developments and lack the transformative impact of major scientific breakthroughs or policy changes.


----
_model_params = {'model': 'nex-agi/deepseek-v3.1-nex-n1:free', 'input': '20150311-three-more-retractions.txt', 'reasoning': {'effort': 'high'}, 'text': {'verbosity': 'medium'}, 'prompt-template': 'prompt-template-2'}_